From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q4 2021 call → NOWe need answer YES or NO. Need analyze transcript. Question asks: Does management describe that company has recently crossed from candidate to approved/specified/listed/qualified/etc. inside buyers' purchasing systems, so future business can arrive without discrete selling event, and that this access is new enough most volume still ahead? Need use only transcript. Transcript: management discusses partnerships with hyperscalers, certifications, alliances. They say "we delivered new alliances with Microsoft and Google Cloud in fourth quarter. And just last week, we announced global alliance with Amazon Web Services... Our ability to now bring best technologies from three largest hyperscalers... huge asset... huge part of growth strategy... participate in expanded market opportunity." They talk about certifications: "By end of 2021, we earned more than 10,000 Microsoft Azure certifications, up from about 1,000 at end of 2020... AWS certifications to more than 4,100... Google Cloud certifications..." They say "customers increasingly trust Kyndryl to deliver best technologies... not just technology of single partner." They give examples. They say "Our alliances... will drive signings, revenue... targeting roughly $1 billion in signings tied to hyperscaler partnerships, virtually all incremental because we really weren't playing in this space before. ... by next March, we'll enter new fiscal year with about $200 million in annualized margin accretive revenue from signings tied to those ecosystem partners." This sounds like partnerships give access to ecosystem, but is that "approved, specified, listed, qualified, registered, reimbursed, pre-authorized choice inside buyers' own purchasing systems"? The question is about being placed into buyer's routine pathway, e.g., approved vendor list, formulary, etc. Management describes alliances with hyperscalers, certifications, co-selling. But does that mean company is now inside buyers' purchasing systems? They are partnering with technology providers, not necessarily being listed on buyer's approved supplier list. They are gaining certifications to sell cloud services. That is more like becoming qualified to sell through partner ecosystem, not being placed into customer's procurement system.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.